NCT03212937 2021-04-28Phase I Trial of Selinexor (KPT-330) and Ifosfamide, Carboplatin, Etoposide (ICE) in Peripheral T-cell LymphomaNational Cancer Centre, SingaporePhase 1 Completed11 enrolled